Synopsis The global Biological Sterile Wound Protection Film market size was valued at USD 123.5 million in 2022 and is forecast to a readjusted size of USD 213.5 million by 2029 with a CAGR of 8.1% during review period. The film can be used for .....
SynopsisThe global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market size is expected to reach US$ 24730 million by 2029, growing at a CAGR of 14.7% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmac.....
SynopsisThe global Bioprocess Bags and Containers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Bioprocess Bags and Containers is e.....
SynopsisPhysical positioning for radiotherapy involves the accurate and reproducible alignment of a patient in a specific position to ensure that the radiation beams precisely target the tumor while minimizing exposure to surrounding healthy tissues. The goal is to de.....
SynopsisEpilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or.....
SynopsisFoot Pumps are clinically proven as a treatment for Deep Venous Thrombosis (DVT), a condition where a blood clot forms inside a vein that is deep inside the body. The global Antithrombotic Pump market was valued at US$ 752 million in 2023 and is anticipa.....
SynopsisSignifor is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. The global Signifor Drugs market was valued at US$ 104.5 million in 2023 and is antici.....
Synopsis The global Intracranial Treatment Drug market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Intracranial Treatment Drug is estimated to incre.....
SynopsisAlzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. The global Alzheimer Treatment Drug market was .....
SynopsisNF1 is a debilitating genetic condition that affects one in every 3,000 to 4,000 individuals. It is caused by a spontaneous or inherited mutation in the NF1 gene and is associated with many symptoms, including soft lumps on and under the skin (cutaneous neurof.....
